SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b):
SEC Accession No. 0001144204-17-000636
Filing Date
2017-01-04
Accepted
2017-01-05 11:55:42
Documents
3
Period of Report
2016-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K12B v456019_8k12b.htm 8-K12B 59897
2 EXHIBIT 1.1 v456019_ex1-1.htm EX-1.1 259936
3 EXHIBIT 10.5 v456019_ex10-5.htm EX-10.5 46769
  Complete submission text file 0001144204-17-000636.txt   368379
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K12B | Act: 34 | File No.: 001-37977 | Film No.: 17509584
SIC: 2834 Pharmaceutical Preparations